Literature DB >> 2525178

High affinity serotonin binding sites in human brain: a comparison of cerebral cortex and basal ganglia.

A J Cross1, P Slater.   

Abstract

The high-affinity binding of 3H-serotonin and 3H-DPAT was studied in membrane preparations and tissue sections of cerebral cortex and basal ganglia of human brain. In tissue sections, 3H-serotonin bound to sites present at high density in the cerebral cortex, hippocampus and basal ganglia. 3H-DPAT bound predominantly to the outer layers of the cerebral cortex and the hippocampus, no significant binding was observed in the basal ganglia. In cortical membranes 3H-serotonin bound to a heterogeneous population of sites, one of which was similar to a binding site labelled by 3H-DPAT (the putative 5HT-1A receptor). 3H-serotonin binding to membranes prepared from the putamen displayed low affinity for DPAT, mesulergine and spiperone, RU24969 was considerably less potent than serotonin itself. This 3H-serotonin binding site does not have the properties of those sites described in rodent brain (5HT-1A, 5HT-1B, and 5HT-1C), and may represent a novel serotoninergic binding site.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2525178     DOI: 10.1007/bf01260506

Source DB:  PubMed          Journal:  J Neural Transm            Impact factor:   3.575


  27 in total

1.  Serotonin and lysergic acid diethylamide binding in rat brain membranes: relationship to postsynaptic serotonin receptors.

Authors:  J P Bennett; S H Snyder
Journal:  Mol Pharmacol       Date:  1976-05       Impact factor: 4.436

2.  Characterization and localization of serotonin receptors in human brain postmortem.

Authors:  A Biegon; S Kargman; L Snyder; B S McEwen
Journal:  Brain Res       Date:  1986-01-15       Impact factor: 3.252

3.  An inhibitory prejunctional 5-HT1-like receptor in the isolated perfused rat kidney. Apparent distinction from the 5-HT1A, 5-HT1B and 5-HT1C subtypes.

Authors:  K G Charlton; R A Bond; D E Clarke
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1986-01       Impact factor: 3.000

4.  Interactions of [3H]LSD with serotonin receptors in human brain.

Authors:  A J Cross
Journal:  Eur J Pharmacol       Date:  1982-08-13       Impact factor: 4.432

5.  Serotonin release in human cerebral cortex and its modulation via serotonin receptors.

Authors:  E Schlicker; F Brandt; K Classen; M Göthert
Journal:  Brain Res       Date:  1985-04-08       Impact factor: 3.252

6.  Autoreceptor-mediated inhibition of 3H-5-hydroxytryptamine release from rat brain cortex slices by analogues of 5-hydroxytryptamine.

Authors:  M Göthert; E Schlicker
Journal:  Life Sci       Date:  1983-03-14       Impact factor: 5.037

7.  Discrimination of multiple [3H]5-hydroxytryptamine binding sites by the neuroleptic spiperone in rat brain.

Authors:  N W Pedigo; H I Yamamura; D L Nelson
Journal:  J Neurochem       Date:  1981-01       Impact factor: 5.372

8.  Serotonin receptors in the human brain. II. Characterization and autoradiographic localization of 5-HT1C and 5-HT2 recognition sites.

Authors:  D Hoyer; A Pazos; A Probst; J M Palacios
Journal:  Brain Res       Date:  1986-06-18       Impact factor: 3.252

9.  Distribution of serotonin-1A receptors in the monkey and the postmortem human hippocampal region. A quantitative autoradiographic study using the selective agonist [3H]8-OH-DPAT.

Authors:  C Köhler; A C Radesäter; W Lang; V Chan-Palay
Journal:  Neurosci Lett       Date:  1986-12-03       Impact factor: 3.046

10.  Pharmacological differentiation and characterization of 5-HT1A, 5-HT1B, and 5-HT1C binding sites in rat frontal cortex.

Authors:  S J Peroutka
Journal:  J Neurochem       Date:  1986-08       Impact factor: 5.372

View more
  1 in total

1.  Antemortem measurements of neurotransmission: possible implications for pharmacotherapy of Alzheimer's disease and depression.

Authors:  P T Francis; M N Pangalos; P H Stephens; J R Bartlett; P K Bridges; A L Malizia; D Neary; A W Procter; D J Thomas; D M Bowen
Journal:  J Neurol Neurosurg Psychiatry       Date:  1993-01       Impact factor: 10.154

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.